scholarly journals O12.6 Minority HIV/AIDS Research Initiative: Advancing HIV Prevention and Treatment Through Data-Informed Research, Community-Informed Practices and Innovative Intervention Strategies

Author(s):  
H King ◽  
O Martinez ◽  
D Duncan ◽  
E Fields ◽  
S Hussen ◽  
...  
2012 ◽  
Vol 3 (1) ◽  
pp. 52
Author(s):  
Donald T. Campbell ◽  
Beatrice J. Krauss

This paper provides a speculative discussion on what quasi-experimental designs might be useful in various aspects of HIV/AIDS research. The first author’s expertise is in research design, not HIV, while the second author has been active in HIV prevention research. It is hoped that it may help the HIV/AIDS research community in discovering and inventing an expanded range of possibilities for valid causal inference. DOI:10.2458/azu_jmmss_v3i1_campbell


2012 ◽  
Vol 3 (1) ◽  
pp. 52
Author(s):  
Donald T. Campbell ◽  
Beatrice J. Krauss

This paper provides a speculative discussion on what quasi-experimental designs might be useful in various aspects of HIV/AIDS research. The first author’s expertise is in research design, not HIV, while the second author has been active in HIV prevention research. It is hoped that it may help the HIV/AIDS research community in discovering and inventing an expanded range of possibilities for valid causal inference. DOI:10.2458/azu_jmmss_v3i1_campbell


Author(s):  
Kia Lilly Caldwell

Brazil has been long considered a global leader in HIV/AIDS prevention and treatment; however, little is known about the effectiveness of these prevention and treatment efforts for the Afro-Brazilian population. This chapter examines the shift toward greater government action focused on HIV prevention for Afro-Brazilians. The chapter also explores HIV prevention initiatives developed by black women’s organizations and how the dynamics of gender, race, and class shape HIV vulnerability for Afro-Brazilian women. Finally, this chapter examines critiques of racially specific HIV prevention initiatives and the tensions between universalism and race consciousness that have characterized the shift toward focusing on the black population in HIV prevention efforts.


Sexual Health ◽  
2017 ◽  
Vol 14 (1) ◽  
pp. 59 ◽  
Author(s):  
Abigail W. Batchelder ◽  
Steven Safren ◽  
Avery D. Mitchell ◽  
Ivan Ivardic ◽  
Conall O'Cleirigh

Despite continued advances in HIV prevention and treatment, gay and bisexual men and other men who have sex with men (MSM) remain the population most impacted by HIV/AIDS in the US and many other Western countries. Additionally, MSM are disproportionately affected by various psychological problems, including depression, distress, trauma and substance use. These challenges frequently co-occur, and are associated with higher rates of behaviours related to HIV acquisition and transmission, HIV infection, and, for those living with HIV/AIDS, lower levels of treatment engagement. Moreover, racial disparities exist among MSM in the US; for example, young African American MSM bear a disproportionate burden of the continuing HIV epidemic, likely related to disparate HIV prevalence in partner pools as well as long-standing structural inequities. In this review, the mental health challenges facing MSM primarily in the US, related to HIV and STI prevention and across the HIV care cascade, including HIV diagnosis, engagement and retention in care, and antiretroviral adherence, are illustrated. Disparities among MSM including racial and ethnic, age-related and structural barriers associated with HIV prevention and treatment, as well as current interventions, are also described. Moving forward towards 2020, resources will be needed to assess and implement scalable intervention strategies to address psychological and social barriers to HIV and STI risk reduction and treatment for MSM, with a particular focus on the most vulnerable subpopulations. As access to prevention and treatment strategies expand, and new breakthroughs continue to emerge, behavioural strategies will continue to be needed to reduce risk and increase uptake and engagement among MSM most at risk through 2020 and beyond.


Sexual Health ◽  
2014 ◽  
Vol 11 (2) ◽  
pp. 101 ◽  
Author(s):  
Bill Whittaker

This paper discusses Australia’s response to the 2011 United Nations Political Declaration on HIV/AIDS in the context of recent ground-breaking advances in HIV prevention and treatment. Australia’s progress in responding to these developments is examined and compared with that of eight other countries in Asia and the Pacific. The implications of the 2012 Melbourne Declaration ‘Action on HIV’ is also discussed as a vehicle for generating advocacy to revolutionise Australia’s HIV response and to urge Australia’s leadership in achieving an ‘AIDS-free generation’.


Author(s):  
Andrea L. Mulkins ◽  
Francisco Ibáñez-Carrasco ◽  
Dave Boyack ◽  
Marja J. Verhoef

2021 ◽  
Vol 33 (1) ◽  
pp. 109-115
Author(s):  
Sangeeta Kansal ◽  
Madhutandra Sarkar ◽  
Alok Kumar ◽  
Jaya Chakravarty ◽  
Rakesh Kumar

Background: Understanding the reasons for HIV serostatus disclosure and nondisclosure and how these reasons differ by certain characteristics of the people living with HIV/AIDS (PLWHA) is important for effective HIV prevention intervention strategies. Objectives: This study was undertaken to investigate/identify the reasons for disclosure and nondisclosure of HIV serostatus by PLWHA, and to find out any association between the reasons for disclosure or nondisclosure and certain demographic and clinical characteristics, i.e. age, gender, WHO clinical stage and CD4 count of the study population. Methods: A cross-sectional study was conducted among all patients of 18-49 years with confirmed HIV infection registered at the antiretroviral therapy (ART) center of a tertiary care hospital in eastern Uttar Pradesh, India for one year, from July 2017 to June 2018. Results: The most common reason for disclosure of HIV serostatus was the presence of any family member at the time of collection of HIV test report (68.5%), and the most common reason for not disclosing the serostatus was stigmatization (68%). The reasons for disclosure was found to be associated with the WHO clinical stage of the respondents (p <0.05).  Conclusions: The findings of this study highlights the need for tailoring intervention strategies for improving disclosure decision making according to the specific needs of PLWHA. There is also a need to address the concerns of those who are reluctant to disclose. More emphasis should be given on creating awareness about HIV stigma, on the importance of serostatus disclosure and secondary HIV prevention in the community.


Sign in / Sign up

Export Citation Format

Share Document